Published in Br J Cancer on November 10, 2015
Identification of the Key Genes and Pathways in Esophageal Carcinoma. Gastroenterol Res Pract (2016) 0.75
Enhanced construction of gene regulatory networks using hub gene information. BMC Bioinformatics (2017) 0.75
Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the JAK2 gene in non-small cell lung cancer. Oncotarget (2017) 0.75
Expression and alternative splicing of the cyclin-dependent kinase inhibitor-3 gene in human cancer. Int J Biochem Cell Biol (2017) 0.75
The genomic dynamics during progression of lung adenocarcinomas. J Hum Genet (2017) 0.75
An integrated map of genetic variation from 1,092 human genomes. Nature (2012) 59.82
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature (2012) 31.78
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov (2012) 26.98
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal (2013) 19.54
Discovery and saturation analysis of cancer genes across 21 tumour types. Nature (2014) 11.68
Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma (1997) 11.04
Comprehensive molecular profiling of lung adenocarcinoma. Nature (2014) 11.02
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med (2008) 10.12
Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One (2010) 3.96
Phosphatases: providing safe passage through mitotic exit. Nat Rev Mol Cell Biol (2011) 2.19
Implementing personalized medicine in a cancer center. Cancer J (2011) 1.69
Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2. Mol Cell (2001) 1.59
Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity. J Biol Chem (1999) 1.56
Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin. Science (1995) 1.49
KAP: a dual specificity phosphatase that interacts with cyclin-dependent kinases. Proc Natl Acad Sci U S A (1994) 1.45
Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression. Mol Cell Biol (2000) 1.19
Aberrant splicing of cyclin-dependent kinase-associated protein phosphatase KAP increases proliferation and migration in glioblastoma. Cancer Res (2007) 1.17
Iterative rank-order normalization of gene expression microarray data. BMC Bioinformatics (2013) 1.06
The tumor suppressor CDKN3 controls mitosis. J Cell Biol (2013) 1.01
Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma. Cancer Res (2000) 1.00
Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer. PLoS One (2013) 0.99
JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrations. Sci Rep (2013) 0.99
SHP2E76K mutant promotes lung tumorigenesis in transgenic mice. Carcinogenesis (2014) 0.97
Critical role of Shp2 in tumor growth involving regulation of c-Myc. Genes Cancer (2010) 0.96
Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma. Oncotarget (2015) 0.95
Abolishment of the interaction between cyclin-dependent kinase 2 and Cdk-associated protein phosphatase by a truncated KAP mutant. Biochem Biophys Res Commun (2003) 0.90
Essential role for Cdk2 inhibitory phosphorylation during replication stress revealed by a human Cdk2 knockin mutation. Proc Natl Acad Sci U S A (2013) 0.88
Expression of integrin alpha 10 is transcriptionally activated by pRb in mouse osteoblasts and is downregulated in multiple solid tumors. Cell Death Dis (2013) 0.83
Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis. Cancer Inform (2015) 0.82